01 54ALPHARMA PHARMS
02 19NALPROPION
03 12PFIZER
01 17375111
02 67682633
03 67682634
04 127815934
05 18088786
06 68158156
07 18318788
08 68623418
09 128685443
10 68685444
11 18722085
12 68846104
13 68877247
14 18916195
15 19107837
16 19125868
17 19248123
18 19633575
19 110231964
20 110307376
21 110403170
22 110828294
23 110835527
24 111033543
25 111139056
26 111324741
27 111998542
28 112048769
01 85Blank
01 38Y
02 47Blank
01 12025-03-26
02 182025-07-03
03 12027-06-04
04 302027-06-19
05 52027-11-08
06 122027-12-12
07 12029-02-03
08 12029-05-29
09 62029-11-07
10 12030-02-02
11 12031-01-10
12 12032-01-13
13 22033-06-05
14 12033-06-25
15 42034-07-02
Patent Expiration Date : 2025-07-03
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8685443
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1508
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2025-07-03
Patent Expiration Date : 2025-07-03
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8685443
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1508
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2025-07-03
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 7682633
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8158156
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 7682633
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8158156
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 7682633
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8158156
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1510
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
Patent Expiration Date : 2025-07-03
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8685443
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1508
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2025-07-03
